Veradigm Inc. (MDRX)
OTCMKTS · Delayed Price · Currency is USD
4.600
+0.100 (2.22%)
Mar 23, 2026, 3:47 PM EST
Veradigm Market Cap
Veradigm has a market cap or net worth of $782.06 million as of March 23, 2026. Its market cap has decreased by -9.57% in one year.
Market Cap
782.06M
Enterprise Value
554.91M
Revenue
588.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
$4.60
Market Cap Chart
Since October 13, 2008, Veradigm's market cap has increased from 311.82M to 782.06M, an increase of 150.80%. That is a compound annual growth rate of 5.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 765.06M | -6.24% |
| Dec 31, 2025 | 815.97M | -50.64% |
| Dec 31, 2024 | 1.65B | 44.24% |
| Dec 29, 2023 | 1.15B | -40.53% |
| Dec 30, 2022 | 1.93B | -14.77% |
| Dec 31, 2021 | 2.26B | -0.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Revium Rx. | 91.09M |
| Vaso Corporation | 30.58M |
| Veri Medtech Holdings | 30.00M |
| CareView Communications | 18.10M |
| Welsis | 12.66M |
| Resilient Healthcare | 12.13M |
| Pharma-Bio Serv | 10.90M |
| BioRegenx | 10.58M |